A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

Clinical trial NCT05644977 · COMPLETED

Trial details

NCT number: NCT05644977
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Alzheimer's Disease Dementia

Start date: 2022-12-02
Primary completion: 2025-04-14
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.